Abstract
Human immunodeficiency virus (HIV) infection first manifested itself as Acquired Immune Deficiency Syndrome (AIDS) in the early 1980s when young, previously healthy homosexual men presented with Pneumocystis carinii pneumonia (PCP). Since the discovery of HIV and AIDS, many different respiratory infections (common, uncommon and opportunistic), as well as different malignancies such as Kaposis sarcoma, and destructive lung processes, such as emphysema have been shown to occur more commonly in the setting of HIV. Alterations in the CD4+/CD8+ lymphocyte composition and changes in the function of B cells compromise host defenses and predispose an HIV infected individual to respiratory infections. Highly Active Antiretroviral Therapy (HAART) has dramatically altered the course of HIV infection through suppression of viral replication, a reconstitution of CD4+ cells, and the resultant decrease in opportunistic infections, including PCP. This manuscript provides a contemporary review of the respiratory diseases of patients with HIV.
Keywords: Pneumocystis carinii pneumonia (PCP), (HAART), cytomegalovirus infections, lower lung diffusing capacity (DLCO), tuberculosis (TB), Mini-Bronchoalveolar Lavage, Kaposi's Sarcoma, Lymphoma, Immunocompetence
Current Respiratory Medicine Reviews
Title: HIV and Respiratory Disease: A Contemporary Perspective
Volume: 1 Issue: 3
Author(s): Albert E. Holt IV, Wendy Turenne and Anthony D. Slonim
Affiliation:
Keywords: Pneumocystis carinii pneumonia (PCP), (HAART), cytomegalovirus infections, lower lung diffusing capacity (DLCO), tuberculosis (TB), Mini-Bronchoalveolar Lavage, Kaposi's Sarcoma, Lymphoma, Immunocompetence
Abstract: Human immunodeficiency virus (HIV) infection first manifested itself as Acquired Immune Deficiency Syndrome (AIDS) in the early 1980s when young, previously healthy homosexual men presented with Pneumocystis carinii pneumonia (PCP). Since the discovery of HIV and AIDS, many different respiratory infections (common, uncommon and opportunistic), as well as different malignancies such as Kaposis sarcoma, and destructive lung processes, such as emphysema have been shown to occur more commonly in the setting of HIV. Alterations in the CD4+/CD8+ lymphocyte composition and changes in the function of B cells compromise host defenses and predispose an HIV infected individual to respiratory infections. Highly Active Antiretroviral Therapy (HAART) has dramatically altered the course of HIV infection through suppression of viral replication, a reconstitution of CD4+ cells, and the resultant decrease in opportunistic infections, including PCP. This manuscript provides a contemporary review of the respiratory diseases of patients with HIV.
Export Options
About this article
Cite this article as:
Holt IV E. Albert, Turenne Wendy and Slonim D. Anthony, HIV and Respiratory Disease: A Contemporary Perspective, Current Respiratory Medicine Reviews 2005; 1 (3) . https://dx.doi.org/10.2174/157339805774597947
DOI https://dx.doi.org/10.2174/157339805774597947 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The State-of-Art in Angiogenic Properties of Latex from Different Plant Species
Current Angiogenesis (Discontinued) Large-Scale Production Means for the Manufacturing of Lentiviral Vectors
Current Gene Therapy Recent Advances in Validating MDM2 as a Cancer Target
Anti-Cancer Agents in Medicinal Chemistry Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases
Current Protein & Peptide Science Cancer Stem Cells and the Tumor Microenvironment: Soloists or Choral Singers
Current Pharmaceutical Biotechnology Chemokine Receptor-directed Agents as Novel Anti-HIV-1 Therapies
Current Topics in Medicinal Chemistry Carbohydrate-Metal Complexes and their Potential as Anticancer Agents
Current Medicinal Chemistry Mesothelioma - Update on Management
Current Respiratory Medicine Reviews Biomarkers and Future Targets for Development in Amyotrophic Lateral Sclerosis
Current Medicinal Chemistry New Perspectives of HIV/AIDS Therapy Study
Recent Patents on Anti-Infective Drug Discovery Peptide-Mediated Cellular Delivery of Oligonucleotide-Based Therapeutics In Vitro: Quantitative Evaluation of Overall Efficacy Employing Easy to Handle Reporter Systems
Current Pharmaceutical Design T Cell Replicative Senescence in Human Aging
Current Pharmaceutical Design Synthetic and Natural Immunomodulators Acting as Interferon Inducers
Current Pharmaceutical Design Innate Immunity and Intracellular Trafficking: Insights for Novel Anti- HIV-1 Therapeutics
Current Pharmacogenomics Therapeutic Targets for Metastatic Prostate Cancer
Current Drug Targets CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
Current Cancer Drug Targets Gene Therapy for Chronic Granulomatous Disease: Current Status and Future Perspectives
Current Gene Therapy Editorial
Current Medical Imaging Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Current Pharmaceutical Design Molecular Approaches to Cervical Cancer Therapy
Current Drug Discovery Technologies